These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
130 related articles for article (PubMed ID: 25154787)
41. Cell surface syndecan-1 on distinct cell types differs in fine structure and ligand binding of its heparan sulfate chains. Kato M; Wang H; Bernfield M; Gallagher JT; Turnbull JE J Biol Chem; 1994 Jul; 269(29):18881-90. PubMed ID: 8034644 [TBL] [Abstract][Full Text] [Related]
42. Syndecan-1 in liver pathophysiology. Reszegi A; Tátrai P; Regős E; Kovalszky I; Baghy K Am J Physiol Cell Physiol; 2022 Aug; 323(2):C289-C294. PubMed ID: 35704700 [TBL] [Abstract][Full Text] [Related]
43. Genesis of placental sequestration in malaria and possible targets for drugs for placental malaria. Clark RL Birth Defects Res; 2019 Jun; 111(10):569-583. PubMed ID: 30919596 [TBL] [Abstract][Full Text] [Related]
44. Acute UV irradiation increases heparan sulfate proteoglycan levels in human skin. Jung JY; Oh JH; Kim YK; Shin MH; Lee D; Chung JH J Korean Med Sci; 2012 Mar; 27(3):300-6. PubMed ID: 22379342 [TBL] [Abstract][Full Text] [Related]
45. Heparanase-mediated loss of nuclear syndecan-1 enhances histone acetyltransferase (HAT) activity to promote expression of genes that drive an aggressive tumor phenotype. Purushothaman A; Hurst DR; Pisano C; Mizumoto S; Sugahara K; Sanderson RD J Biol Chem; 2011 Sep; 286(35):30377-30383. PubMed ID: 21757697 [TBL] [Abstract][Full Text] [Related]
46. Deletion of Lymphangiogenic and Angiogenic Growth Factor VEGF-D Leads to Severe Hyperlipidemia and Delayed Clearance of Chylomicron Remnants. Tirronen A; Vuorio T; Kettunen S; Hokkanen K; Ramms B; Niskanen H; Laakso H; Kaikkonen MU; Jauhiainen M; Gordts PLSM; Ylä-Herttuala S Arterioscler Thromb Vasc Biol; 2018 Oct; 38(10):2327-2337. PubMed ID: 30354205 [TBL] [Abstract][Full Text] [Related]
47. Pathophysiology of Diabetic Dyslipidemia. Hirano T J Atheroscler Thromb; 2018 Sep; 25(9):771-782. PubMed ID: 29998913 [TBL] [Abstract][Full Text] [Related]
48. Anionic biopolyelectrolytes of the syndecan/perlecan superfamily: physicochemical properties and medical significance. Siegel G; Malmsten M; Ermilov E Adv Colloid Interface Sci; 2014 Mar; 205():275-318. PubMed ID: 24534475 [TBL] [Abstract][Full Text] [Related]
49. Gene expression of syndecans and betaglycan in isolated rat liver cells. Weiner OH; Zoremba M; Gressner AM Cell Tissue Res; 1996 Jul; 285(1):11-6. PubMed ID: 8766853 [TBL] [Abstract][Full Text] [Related]
50. Sterol carrier protein-2 deficiency attenuates diet-induced dyslipidemia and atherosclerosis in mice. He H; Wang J; Yannie PJ; Kakiyama G; Korzun WJ; Ghosh S J Biol Chem; 2018 Jun; 293(24):9223-9231. PubMed ID: 29700117 [TBL] [Abstract][Full Text] [Related]
52. Intraluminal tranexamic acid inhibits intestinal sheddases and mitigates gut and lung injury and inflammation in a rodent model of hemorrhagic shock. Peng Z; Ban K; LeBlanc A; Kozar RA J Trauma Acute Care Surg; 2016 Aug; 81(2):358-65. PubMed ID: 27027557 [TBL] [Abstract][Full Text] [Related]
58. Changes in matrix proteoglycans induced by insulin and fatty acids in hepatic cells may contribute to dyslipidemia of insulin resistance. Olsson U; Egnell AC; Lee MR; Lundén GO; Lorentzon M; Salmivirta M; Bondjers G; Camejo G Diabetes; 2001 Sep; 50(9):2126-32. PubMed ID: 11522680 [TBL] [Abstract][Full Text] [Related]